Ozempic is making its presence known on menus, and the forecast for dumplings is 100% sunshine.

Patients taking either a GLP-1 or SGLT2 drug had a 74% lower risk of death and an 84% lower risk of a heart attack within an ...

These are just some of the ways in which analysts forecast that the new wave of incredibly effective weight-loss drugs, known ...

News of these promising findings come after a banner press year for GLP-1s, which have exploded in popularity as weight ...

Wegovy is now a household name. If not for Novo Nordisk’s Lotte Bjerre Knudsen, the GLP-1 drugs it represents might have been a footnote in drug development history. Evidence started ...

From transformative weight loss treatment to a potential blockbuster for Alzheimer's, Dave Ricks of Eli Lilly is having a ...

A new class of drugs is set to join their ranks and has the potential to eclipse them all—GLP-1 receptor agonists. These drugs mimic the action of a naturally occurring hormone, glucagon-like ...

Share on Pinterest A recent study found significant reductions in opioid overdose and alcohol misuse among people taking GLP-1 drugs like Ozempic. FreshSplash/Getty Images A new study shows a 50% ...

The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, ...

Negotiations on the sale of a stake in GLP Pte’s China operations to Guangdong Holdings Ltd. have stalled due to disagreements over deal terms, according to people familiar with the situation.

The company benefits from GLP-1 drug sales and is positioned for high margins and recurring revenues in the growing healthcare market. HIMS achieved positive operating income with 50% revenue ...

The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and gastrointestinal endoscopies, according to updated guidance from five ...